Evgen Pharma (EVG) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Oct 2022 07:00 AM
RNS
Clinical trial update
10 Oct 2022 11:05 AM
RNS
Second Price Monitoring Extn
10 Oct 2022 11:00 AM
RNS
Price Monitoring Extension
10 Oct 2022 07:00 AM
RNS
SFX-01 licensing deal for up to $160.5m
29 Sep 2022 07:00 AM
RNS
Regulatory approval for healthy volunteer study
22 Jul 2022 07:00 AM
RNS
Result of AGM
14 Jul 2022 12:43 PM
RNS
Investor Presentation
06 Jul 2022 12:25 PM
RNS
Notice of AGM
13 Jun 2022 07:00 AM
RNS
Collaboration with University of Michigan
08 Jun 2022 07:00 AM
RNS
Full Year Results
07 Jun 2022 07:00 AM
RNS
Notice of Results
25 May 2022 07:00 AM
RNS
Collaboration with Università Sapienza di Roma
29 Apr 2022 02:39 PM
RNS
Holding(s) in Company
15 Mar 2022 02:05 PM
RNS
Second Price Monitoring Extn
15 Mar 2022 02:00 PM
RNS
Price Monitoring Extension
07 Mar 2022 07:00 AM
RNS
Manchester Breast Centre collaboration expanded
18 Jan 2022 07:00 AM
RNS
Option over new sulforaphane analogues
11 Jan 2022 07:00 AM
RNS
Progress with UK and US regulators for 2022 trials
30 Dec 2021 11:35 AM
RNS
Holding(s) in Company
08 Dec 2021 02:08 PM
RNS
Grant of Options
07 Dec 2021 07:00 AM
RNS
Half-year Report
23 Nov 2021 07:00 AM
RNS
Notice of Results
10 Nov 2021 07:00 AM
RNS
Publication of data on SFX-01 in glioblastoma
19 Oct 2021 02:39 PM
RNS
Holding(s) in Company
20 Sep 2021 07:00 AM
RNS
Publication of data in glioblastoma cells
02 Sep 2021 02:32 PM
RNS
Holding(s) in Company
02 Sep 2021 02:06 PM
RNS
Second Price Monitoring Extn
02 Sep 2021 02:00 PM
RNS
Price Monitoring Extension
02 Sep 2021 11:05 AM
RNS
Second Price Monitoring Extn
02 Sep 2021 11:01 AM
RNS
Glioma Orphan Drug designation granted by FDA
02 Sep 2021 11:00 AM
RNS
Price Monitoring Extension
25 Aug 2021 04:42 PM
RNS
Holding(s) in Company
24 Aug 2021 04:41 PM
RNS
Second Price Monitoring Extn
24 Aug 2021 04:36 PM
RNS
Price Monitoring Extension
09 Aug 2021 05:06 PM
RNS
Holding(s) in Company
20 Jul 2021 11:57 AM
RNS
Holding(s) in Company
16 Jul 2021 01:50 PM
RNS
Holding(s) in Company
14 Jul 2021 10:23 AM
RNS
Holding(s) in Company
13 Jul 2021 05:02 PM
RNS
Result of AGM and Business Update
13 Jul 2021 03:55 PM
RNS
Holding(s) in Company
13 Jul 2021 07:00 AM
RNS
Early data for SFX-01 in leukaemia cell lines
13 Jul 2021 07:00 AM
RNS
Glioma Orphan Drug application submitted to US FDA
09 Jul 2021 11:05 AM
RNS
Second Price Monitoring Extn
09 Jul 2021 11:00 AM
RNS
Price Monitoring Extension
09 Jul 2021 07:00 AM
RNS
Interim Safety and Futility Analysis - STAR trial
18 Jun 2021 07:00 AM
RNS
Posting of Annual Report and Notice of AGM
15 Jun 2021 07:00 AM
RNS
Final Results
14 Jun 2021 07:00 AM
RNS
Progress with Glioma/Glioblastoma programme
14 Jun 2021 07:00 AM
RNS
Progress on metastatic breast cancer programme
26 Apr 2021 07:00 AM
RNS
Appointment of Chief Medical Officer
UK 100

Latest directors dealings